Roivant’s anti-inflammatory drug succeeds in mid-stage study By Reuters
By Bhanvi Satija (Reuters) - Roivant Sciences (NASDAQ:) announced on Tuesday that its experimental drug for non-infectious uveitis showed promising ...
Tag: Roivants
The latest news and updates about the AI Technology and Latest Tech Updates around the world... PouroverAI keeps you in the loop.